Merck-Moderna vaccine reduces odds of skin cancer recurrence, study finds
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.